Opna Bio Doses First Patient in Phase 1 Study in Multiple Myeloma with OPN-6602, an EP300/CBP Bromodomain Inhibitor by Seini Moimoi | Aug 26, 2024 | Portfolio News
BioAge Appoints Former GSK CEO Jean-Pierre Garnier as Chair of Its Board of Directors by Seini Moimoi | Aug 22, 2024 | Portfolio News
89bio Appoints Francis Sarena as Chief Operating Officer by Seini Moimoi | Aug 7, 2024 | Portfolio News
BioAge Announces First Patient Dosed in the STRIDES Phase 2 Clinical Trial Evaluating Azelaprag as a Novel Treatment for Obesity in Combination with Tirzepatide by Seini Moimoi | Jul 29, 2024 | Portfolio News
Viridian Therapeutics Announces Completion of THRIVE-2 Enrollment for VRDN-001 in Patients with Chronic Thyroid Eye Disease (TED) by Seini Moimoi | Jul 25, 2024 | Portfolio News
Mirum’s LIVMARLI Now Approved for PFIC in Patients 12 Months and Older by Seini Moimoi | Jul 25, 2024 | Portfolio News
Inozyme Pharma Publishes Preclinical Data Supporting INZ-701 as a Potential Therapy for a Broad Range of Serious Rare Diseases Impacting Bone Health and Blood Vessel Function by Seini Moimoi | Jul 25, 2024 | Portfolio News
Kestra Medical Technologies Announces $196 Million Oversubscribed Financing Round by Seini Moimoi | Jul 24, 2024 | Portfolio News
Ceribell Announces Publication of Study Demonstrating Significant Reduction in Length of ICU Stays and Better Patient Outcomes with Ceribell Point-of-Care EEG Compared to Conventional EEG by Seini Moimoi | Jul 22, 2024 | Portfolio News
Sydnexis welcomes Perry J. Sternberg as Chief Executive Officer by Seini Moimoi | Jul 16, 2024 | Portfolio News